Title:
新規化合物
Document Type and Number:
Japanese Patent JP2022532096
Kind Code:
A
Abstract:
本明細書に開示されるのは、新規のＣ－マンノシド化合物及び組成物、並びにヒト疾患の治療のための医薬品としてのそれらの適用である。ヒト対象におけるＦｉｍＨの活性を阻害する方法はまた、疾患、例えば、尿路感染症の治療のために提供される。
Inventors:
Michael, joseph, bishop
James, Walter, Janecca
Laurel, Kathryn, McGrain
Eugene, Lee, Stewart
Catherine, Louisa, Widson
James, Walter, Janecca
Laurel, Kathryn, McGrain
Eugene, Lee, Stewart
Catherine, Louisa, Widson
Application Number:
JP2021566037A
Publication Date:
July 13, 2022
Filing Date:
May 06, 2020
Export Citation:
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
FIMBRION THERAPEUTICS, INC.
FIMBRION THERAPEUTICS, INC.
International Classes:
C07D405/10; A61K31/351; A61K31/4433; A61K31/497; A61K31/498; A61K31/501; A61P1/04; A61P13/02; A61P29/00; A61P31/04; C07D309/10
Attorney, Agent or Firm:
Nakamura Yukitaka
Miyajima Manabu
Asano Mari
Keiyasu Suzuki
Miyajima Manabu
Asano Mari
Keiyasu Suzuki
Previous Patent: Multilayer material for screening and removing UV light, composition containing it, processing proce...
Next Patent: Ferrofluid
Next Patent: Ferrofluid